Plasmid DNA (pDNA) constructs are used for a number of key applications, including gene therapy and mRNA. Manufacturing plasmids is therefore a crucial part of biotechnology. A good manufacturing ...
The viral vector and plasmid DNA manufacturing market offers growth opportunities in gene therapies, contract manufacturing, and emerging markets like Asia-Pacific. Key trends include rising demand ...
Hopewell-based team delivers on ProBio's promise of speed, quality, and reliability—offering a transparent, fixed-cost model and ≥85% supercoiled plasmid DNA in record time for clinical programs. At ...
Charles River Laboratories International, Inc. CRL recently announced a plasmid DNA manufacturing alliance with INADcure Foundation. The collaboration will leverage Charles River’s market-leading ...
DUBLIN, July 13, 2023 /PRNewswire/ -- The "Viral Vector and Plasmid DNA Manufacturing Market - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global viral ...
The MarketWatch News Department was not involved in the creation of this content. Viral Vectors and Plasmid DNA Manufacturing Market to Reach $34.0 billion by 2033 at 20.4% CAGR: Allied Market ...
STONY BROOK, NY / ACCESSWIRE / September 17, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced its participation at upcoming mRNA ...
Plasmid DNA is critical for cell and gene therapies, but scaling high-purity production remains challenging as CDMO partners ...
STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, announced the formal launch of business development ...
Increase in funding for R&D activities, surge in awareness regarding gene therapy, and rise in prevalence of cancer, viral infections, and genetic disorders drive the growth of global viral vectors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results